Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Missouri Valley Cancer Consortium | Researchclopedia

Back to institutions

Missouri Valley Cancer Consortium

Omaha, Nebraskanonprofit

104

Works

21,404

Citations

83

h-index

Top Research Topics

Cancer Treatment and Pharmacology Lung Cancer Research Studies Colorectal Cancer Treatments and Studies

Top Researchers

Daniel J. Sargent National Institute of Agricultural Botany

769 works86,357 citationsh-index: 109

Recent Research

Utility of the 70-gene MammaPrint assay for prediction of benefit from extended letrozole therapy (ELT) in the NRG Oncology/NSABP B-42 trial.

Priya Rastogi,Hanna Bandos,et al.

202116 citations

Lung Cancer Treatments and Mutations

Neuroendocrine Tumor Research Advances

Breast Cancer Treatment Studies

Estrogen and related hormone effects

Cancer therapeutics and mechanisms

Gastric Cancer Management and Outcomes

Chemotherapy-related skin toxicity

HER2/EGFR in Cancer Research

Lung Cancer Diagnosis and Treatment

Jeff A. Sloan Boston University

730 works72,947 citationsh-index: 125

Neil K. Aaronson Dutch Cancer Society

651 works66,466 citationsh-index: 125

Richard M. Goldberg West Virginia University

1,023 works65,160 citationsh-index: 107

Thomas E. Witzig Toyota Motor Corporation (Switzerland)

1,273 works61,973 citationsh-index: 129

Edith A. Perez Jacksonville College

663 works58,980 citationsh-index: 95

Breast Cancer Index (BCI) and prediction of benefit from extended aromatase inhibitor (AI) therapy (tx) in HR+ breast cancer: NRG oncology/NSABP B-42.

Eleftherios P. Mamounas,Hanna Bandos,et al.

202122 citations

Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance])

Harry H. Yoon,Fang‐Shu Ou,et al.

202121 citations

Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial

Eleftherios P. Mamounas,Hanna Bandos,et al.

2018159 citations

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

Noah Kornblum,Fengmin Zhao,et al.

20180 citations

Abstract S1-02: PrECOG 0102: A randomized, double-blind, phase II trial of fulvestrant plus everolimus or placebo in post-menopausal women with hormone receptor (HR)-positive, HER2-negative metastatic breast cancer (MBC) resistant to aromatase inhibitor (AI) therapy

NS Kornblum,Judith Manola,et al.

201735 citations